Editor: Jean-Marc Sabatier

Coronaviruses

Volume 2

eBook: US $49 Special Offer (PDF + Printed Copy): US $59
Printed Copy: US $84
Library License: US $196
ISSN: 2737-5625 (Print)
ISSN: 2737-5633 (Online)
ISBN: 978-981-4998-61-1 (Print)
ISBN: 978-981-4998-60-4 (Online)
Year of Publication: 2021
DOI: 10.2174/97898149986041210201

Introduction

Scientific literature on SARS-COV-2 viruses and its variants (especially variants of concern such as the ‘Delta variant’) and important cellular targets is crucial to help researchers, epidemiologists, virologists and clinicians around the globe to develop a new generation of safer and more effective vaccines, and other treatments to address COVID-19 disease. The accompanying damage to the many organs and tissues of SARS-Co-2-infected people also needs to be understood and researchers are using data to devise meaningful protocols for treating these symptoms. This second volume of Coronaviruses brings together more useful information about the prevention, vaccination, and chemotherapies for the potential treatment of coronavirus infections. The volume includes eight chapters: (1) Broad spectrum antivirals to combat COVID-19 The reality and challenges, (2) COVID-19: Preventive and protective control management strategies, (3) Plant-derived extracts and bioactive compounds against coronavirus progression: preventive effects, mechanistic aspects, and structures, (4) Gastroenteritis: symptoms and epidemiology of SARS-CoV-2, (5) The chronicles of coronavirus: A Chinese king who conquered the entire world, (6) Traditional medicine as a natural remedy in ARDS & COVID-19, (7) Molecular pathogenesis of human coronaviruses of the 21st century, (8) COVID-19, mental health and neuropathophysiology of pain related to temporomandibular disorder. The volume serves as a novel compilation of key data on SARS-CoV-2 and COVID-19 and represents a resource of the utmost value for all scholars studying SARS-CoV infections. It should also be of great interest to clinicians who may be facing an overwhelming number of individuals affected with COVID-19, with over 267 million global cases documented as of the first week of December 2021).

Audience: Researchers, epidemiologists, virologists and healthcare professionals interested in understanding COVID-19 and the virology of SARS-CoV-2.

Preface

- Pp. i
Jean-Marc Sabatier
Download Free

List of Contributors

- Pp. ii-iii (2)

Download Free

Broad-Spectrum Antivirals to Combat COVID-19: the Reality and Challenges

- Pp. 1-31 (31)
Wafaa A. Hewedy*
View Abstract Download Free

COVID19: Preventive and Protective Control Management Strategies

- Pp. 32-62 (31)
Kalyani Pathak*, Manash Pratim Pathak, Urvashee Gogoi, Riya Saikia, Aparoop Das
View Abstract Download Free

Plant-derived Extracts and Bioactive Compounds against Coronavirus Progression: Preventive Effects, Mechanistic Aspects, and Structures

- Pp. 63-96 (34)
Heba A.S. El-Nashar, Ahmed E. Elissawy, Omayma A. Eldahshan*, Abdel Nasser B. Singab*
View Abstract Download Free

Gastroenteritis: Symptoms and Epidemiology of SARS-CoV-2

- Pp. 97-117 (21)
Aditi Nag, Sudipti Arora, Sonia Sethi*
View Abstract Download Free

The Chronicles of Coronavirus: A Chinese King Who Conquered the Entire World

- Pp. 118-133 (16)
Sanaullah Sajid*, Sajjad-ur Rahman, Muhammad Ali, Maliha Sarfraz, Imran Abdullah, Samiullah Sajid
View Abstract Download Free

Traditional Medicine as Natural Remedy in ARDS & COVID-19 Through Interleukins

- Pp. 134-154 (21)
Suresh Kumar Karri, Sheela Angappan*
View Abstract Download Free

Molecular Pathogenesis of Human Coronaviruses of 21st Century

- Pp. 155-190 (36)
Ruma Karmakar, Satya Vadlamani, Jyoti Verma, Sakshi Kumari, Maitreyi Syamala Rajala*
View Abstract Download Free

COVID-19, Mental Health and Neuropathophysiology of Pain Related to Temporomandibular Disorder

- Pp. 191-214 (24)
Karen Dantur Batista Chaves, Maria Cristina Munerato*
View Abstract Download Free

Subject Index

- Pp. 215-222 (8)

Download Free

RELATED BOOKS

.Frontiers in Clinical Drug Research-Anti-Infectives.
.Frontiers in Anti-infective Agents.
.Infectious Diseases.
.(COVID-19): Different Models and Treatment Strategies.